AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Early SHIV control in monkeys causes long-lasting asymptomatic outcomes.

Vaccine Weekly

| December 10, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 DEC 10 - (NewsRx.com & NewsRx.net) -- Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus (SHIV) chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.

"In contrast to simian immunodeficiency viruses (SIVs), which induce immunodeficiency over a one- to two-year period, highly pathogenic simian-human immunodeficiency viruses (SHIVs) cause an irreversible and systemic depletion of CD4+ T lymphocytes in macaque monkeys within weeks of inoculation. Nonetheless, the seemingly more aggressive SHIVs have proven to be easier to control by the same vaccine regimens that fail to contain SIV," scientists in the United States report.

"Because early events during in vivo infections may determine both the pathogenic consequences of the challenge virus and its sensitivity to interventions that prevent disease, we have evaluated the effects of inoculum size and a potent antiretroviral drug on the development of disease in monkeys infected with SHIVDH12R," stated Tatsuhiko Igarashi and colleagues at the National Institute of Allergy and Infectious Diseases and Cornell University.

"The results obtained show that in a majority of ...

Related articles from newspapers, magazines, journals, and more
Recent findings in herpesvirus described by researchers from National Institute...
Newspaper article from: Virus Weekly October 28, 2008 700+ words
...2410-5). Additional information can be obtained by contacting F. Ban, National Institute of Infectious Diseases, National Institute of Infectious Diseases, Dept. of Virology I, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640...
Xenomics Executes Definitive Agreement with Italy's National Institute for...
Press release article from: Business Wire July 12, 2005 700+ words
...Italy's National Institute for Infectious Diseases -- a respected...Institute as the National Institute for Infectious...generated infectious diseases. About Xenomics...with the National Institute for Infectious Diseases (Instituto...
Investigators at National Institute of Infectious Disease, Infectious Diseases...
Newspaper article from: Virus Weekly October 7, 2008 700+ words
...wrote T. Kubota and colleagues, National Institute of Infectious Disease, Infectious Diseases Department (see also Life Sciences...information, contact T. Kubota, National Institute of Infectious Diseases, Dept. of Virology III, Gakuen...
Studies from National Institute of Infectious Disease, Infectious Diseases...
Newspaper article from: Hepatitis Weekly August 11, 2008 700+ words
...K. Murakami and colleagues, National Institute of Infectious Disease, Infectious Diseases Department. The researchers concluded...obtained by contacting K. Murakami, National Institute of Infectious Diseases, Dept. of Virology II, 1...
Report summarizes mycobacteria study findings from National Institute of...
Newspaper article from: Biotech Week June 3, 2009 700+ words
...K. Tanigawa and colleagues, National Institute of Infectious Disease, Infectious Diseases Department. The researchers concluded...information, contact K. Tanigawa, National Institute of Infectious Diseases, Dept. of Bioregulation, Leprosy...
Xenomics executes definitive agreement with Italy's National Institute for...
News wire article from: Asia Africa Intelligence Wire July 12, 2005 700+ words
...Spallanzani), Italy's National Institute for Infectious Diseases, a respected medical...treatment of serious infectious diseases. Previously, Xenomics...technology in the areas of infectious diseases, such as HIV/AIDS...
Researchers at Japanese National Institute of Infectious Diseases present new...
News wire article from: Chemical Business Newsbase October 23, 2006 700+ words
...Hemispherx Biopharma Inc (Hemispherx) announced that on 20 Oct 2006, Dr Hideki Hasegawa, of Japan's National Institute of Infectious Diseases (JNIID), presented the results of his studies co-administering Hemispherx's double-stranded...
Researchers at Japanese National Institute of Infectious Diseases Present New...
Press release article from: Business Wire October 23, 2006 700+ words
...AMEX: HEB) announced today that on Friday, October 20, Dr. Hideki Hasegawa, of Japan's National Institute of Infectious Diseases (JNIID), presented the results of his studies co-administering Hemispherx's double-stranded...
Japan's NIID extends accord with HemiSpherx.(National Institute of Infectious...
Newspaper article from: Pharma Marketletter September 17, 2007 700+ words
Japan's National Institute of Infectious Diseases (NIID) has extended its relationship with USA-based Hemispherx Biopharma to initiate research on the intranasal co-administration...
Success could be down to donor stem cells. (Cloning).(National Institute of...
Magazine article from: Chemistry and Industry January 21, 2002 700+ words
...genes have featured largely in the problems encountered. Now a study by Japanese scientists from the National Institute of Infectious Diseases, in Tokyo, has found that mice cloned from somatic cells, cells other than egg or sperm cells...
For more facts and information, see all results

Source: HighBeam Research, Early SHIV control in monkeys causes long-lasting asymptomatic...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA